Striving towards disease-free skin
Written by Dr Cathy Zhao Last weekend, Dr Rose Liu (research fellow) and I attended the Australasian Dermatopathology Society Annual Meeting in Melbourne. The meeting was an extremely enlightening learning experience, where we learned about the dermatopathology of various skin conditions including lymphoma, skin infection and alopecia. We also learned about newer immunohistochemistry stains. The …
This year, the Australian and New Zealand Society for Mass Spectrometry Conference (ANZSMS26) was held in Adelaide, South Australia from, Sunday 16 to Thursday 20 July 2017. ANZSMS26 is the premier conference for mass spectrometry in the Australia & New Zealand region with an aim to provide a forum for the presentation of research in …
Congratualations to Dr Shaun Chou, with the paper “PD-1 inhibitor associated lichenoid inflammation with incidental suprabasilar acantholysis or vesiculation – report of four cases” accepted in Journal of Cutaneous Pathology last week. This is a paper about four rare cases of atypical lichenoid reactions with histological blistering, that histologically mimicked paraneoplastic pemphigus. All of the …
Various cutaneous side-effects have been reported with anti-melanoma systemic therapies. BRAF inhibitors, MEK inhibitors, anti-PD1 and anti-CTLA4 molecules have changed the prognosis of patients with metastatic melanoma, improving their chances of survival. Some side effects appear in these patients, including changes in nevi (moles). We have reviewed the changes in our patients on dabrafenib, vermurafenib …
Westmead Oncodermatology is the result of the collaboration of the Department of Dermatology (DOD) at Westmead Hospital and the Skin & Cancer Foundation Australia (SCFA) at Westmead. Oncodermatology is a merge of the Oncology and Dermatology disciplines and works to improve management and research into cancers of the skin. The best source of information available …
In non-melanoma skin cancer, performing a biopsy followed by its histopathological examination is the only method for confirming clinical diagnosis of the tumour. Skin biopsy is not always safe and may lead to complications such as bleeding, wound infection, and scarring. Therefore, the development of non-invasive skin tissue sampling technique without the need for traditional …
Written by Dr Rose Liu My first month as the new dermatology research fellow has been an absolute blast, and it’s been a pleasure to work with such an amazing team! Introductions were kicked off at a gathering at Professor Fernandez-Penas’ house earlier this month, where I was blown away by a scrumptious seafood paella …
Our new reflectance confocal microscopy (RCM), VivaScope® 1500 have arrived at the Department of Dermatology, Westmead Hospital this week. We are proud to be one of the few institutions in Sydney to have a RCM. The term confocal in RCM refers to the CONjugate relationship between the FOCAL planes in which the tissue sample and …
Written by Ali Azimi Recently, our original research paper titled “In Silico Analysis Validates Proteomic Findings of Formalin-fixed Paraffin Embedded Cutaneous Squamous Cell Carcinoma Tissue” has been accepted for publication in the journal of Cancer Genomics & Proteomics (CGP). The manuscript will be published in the next available issue of CGP. CGP is an international …